Archive: 14/02/2020
Ceramides predict vascular brain injury and dementia
Novel blood-based biomarkers for dementia could identify disease at an early preclinical stage, serve as surrogate outcomes for clinical trials of investigational therapies and even identify future potential therapeutic targets. ...
Feb 14, 2020